Adrian Ciurea

Zurich, ZH, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 125 publications

In search of a window of opportunity in axial spondyloarthritis: treatment outcomes across different symptom durations.

In search of a window of opportunity in axial spondyloarthritis: treatment outcomes across different symptom durations.

Journal: EULAR rheumatology open

Published: August 01, 2026

Differential joint-level response to secukinumab in psoriatic arthritis: A collaborative European observational cohort study.

Differential joint-level response to secukinumab in psoriatic arthritis: A collaborative European observational cohort study.

Journal: EULAR rheumatology open

Published: June 29, 2026

Site-specific articular response to TNF inhibitor in axial spondyloarthritis: a European cohort study.

Site-specific articular response to TNF inhibitor in axial spondyloarthritis: a European cohort study.

Journal: Joint bone spine

Published: May 13, 2026

Site-specific articular response to TNF inhibitor in axial spondyloarthritis: A European cohort study.

Site-specific articular response to TNF inhibitor in axial spondyloarthritis: A European cohort study.

Journal: Joint bone spine

Published: May 13, 2026

Site-specific articular responses to b/tsDMARDs in rheumatoid arthritis: a longitudinal observational study from the Swiss Clinical Quality Management Registry.

Site-specific articular responses to b/tsDMARDs in rheumatoid arthritis: a longitudinal observational study from the Swiss Clinical Quality Management Registry.

Journal: RMD open

Published: April 08, 2026

Alterations in Circulating Progenitor Cell Composition in Rheumatoid Arthritis.

Alterations in Circulating Progenitor Cell Composition in Rheumatoid Arthritis.

Journal: Cells

Published: March 17, 2026

Rising overweight and obesity in Swiss psoriatic arthritis patients, 2007-2022: a nationwide registry-population comparison.

Rising overweight and obesity in Swiss psoriatic arthritis patients, 2007-2022: a nationwide registry-population comparison.

Journal: Clinical and experimental rheumatology

Published: February 27, 2026

Influence of national socioeconomic status on treatment retention and disease activity in psoriatic arthritis and axial spondyloarthritis: evidence over 2 years in 13 European countries.

Influence of national socioeconomic status on treatment retention and disease activity in psoriatic arthritis and axial spondyloarthritis: evidence over 2 years in 13 European countries.

Journal: Annals of the rheumatic diseases

Published: February 11, 2026

Defining and validating a high specificity MRI cut-off for the radiographic part of the modified New York criteria in patients with axial spondyloarthritis.

Defining and validating a high specificity MRI cut-off for the radiographic part of the modified New York criteria in patients with axial spondyloarthritis.

Journal: Arthritis research & therapy

Published: January 06, 2026

Effectiveness of TNF inhibitors in patients with very early axial spondyloarthritis, defined as duration of ≤1 year of back pain: longitudinal observational data from the SCQM registry.

Effectiveness of TNF inhibitors in patients with very early axial spondyloarthritis, defined as duration of ≤1 year of back pain: longitudinal observational data from the SCQM registry.

Journal: RMD open

Published: December 15, 2025

Anti-CD74 IgA is not associated with modic changes in the Northern Finland Birth Cohort.

Anti-CD74 IgA is not associated with modic changes in the Northern Finland Birth Cohort.

Journal: Clinical rheumatology

Published: September 30, 2025

Discrepancies between routine sacroiliac joint MRI reporting and current expert recommendations in patients with spondyloarthritis.

Discrepancies between routine sacroiliac joint MRI reporting and current expert recommendations in patients with spondyloarthritis.

Journal: RMD open

Published: September 01, 2025

Showing 1-12 of 125

Last Updated: 09/26/2026